(Q45332898)
Statements
1 reference
Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia (English)
1 reference
Joseph R Calabrese
1 reference
Elizabeth Pappadopulos
1 reference
Keming Gao
1 reference
Onur N Karayal
1 reference
Sheela Kolluri
1 reference
1 June 2013
1 reference
1 reference
33
1 reference
3
1 reference
425-431
1 reference
Identifiers
1 reference
1 reference